AB Science S.A.
ABSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.16 | 0.00 | 8.73 | 3.28 |
| FCF Yield | 0.80% | -38,315,813.84% | -4.57% | -3.18% |
| EV / EBITDA | -11.55 | -1.02 | -26.83 | -44.14 |
| Quality | ||||
| ROIC | -91.25% | -150.40% | -293.77% | -312.54% |
| Gross Margin | 116.42% | 60.52% | 96.76% | 93.09% |
| Cash Conversion Ratio | -0.07 | 1.41 | 1.28 | 1.19 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.82% | -15.49% | -15.41% | 0.76% |
| Free Cash Flow Growth | 102.15% | 4.96% | -2.10% | -27.81% |
| Safety | ||||
| Net Debt / EBITDA | -2.13 | -1.02 | -1.32 | 0.03 |
| Interest Coverage | -2.71 | -3.39 | -7.91 | -10.75 |
| Efficiency | ||||
| Inventory Turnover | -0.96 | 1.14 | 0.07 | 0.79 |
| Cash Conversion Cycle | 12,336.95 | -5,536.84 | -81,052.36 | -20,000.51 |